Prevention and early detection are central to our mission of helping save lives, celebrate lives, and lead the fight against cancer. The healthcare industry, globally, is under competitive and legislative pressure to reduce the cost of care, efficiently manage resources, and improve patient care.

Examining medical images and data is time-consuming and relies on the judgement and skills of highly specialised experts and many a times the interpretation is prone to errors, since humans suffer from factors like fatigue and distractions. This is why patients sometimes have different interpretations from various doctors, which can make choosing a plan of action a stressful and tedious process.

A delay of even half an hour can result in loss of life, and a wrong diagnosis could prove tragic.

We are addressing these issues through our AI-powered platform, which can, among other things, analyse blood samples and generate medical reports in less than 10 minutes — from anywhere and with complete accuracy.


Developing advanced and highly flexible algorithms for medical analysis and interpretation by utilizing cutting-edge deep learning technologies and other advanced solutions.


Building intuitive and data-driven products that are complementary to physicians and their professional efforts of saving lives and delivering efficient and accurate diagnostic decisions.


Creating affordable platforms that are compatible with different desktop and portable devices, giving everyone the opportunity to have an efficient AI solution whenever and wherever they need it.

Our Solutions

Our platform gives the functionality far beyond the microscope. Without the need for physical glass slides, you get access to current and historical images — from anywhere and at any time. It also handles time-consuming tasks so you spend more time actually reviewing cases. Second opinions, external reading resources, and specialists are just a mouse click away. It also makes integrated diagnostic workflows possible, improving collaboration with other medical disciplines.


A versatile platform for research projects, small or big, local or global. Streamline your workflow and collaborate using top quality technology. Affordable from single researcher to large groups. Easily store, share and analyze all your whole slide images. Publish your own images in superior quality in your research papers, articles and blogs


Traditionally, education and training in pathology has been delivered using textbooks, glass slides and conventional microscopy employing it throughout the full spectrum of histopathology learning from undergraduate and post graduate education through to continuous professional development and external quality assurance. Students can learn key histopathological skills, e.g. to identify areas of diagnostic relevance from an entire digital slide.

Market Statistics

An alarming 150 to 200 percent increase in cancer rates is expected by 2030 within the GCC states. This is the highest expected increase in the world, according to medical expert, Dr. Ibtihal Fadil.

Worldwide, there has been a 70 per cent increase in cancer deaths according to World Health Organisation. Globally, $80 billion (Dh 293.84 billion) is spent on cancer treatments annually.

The biggest challenge that we see is that despite increased awareness efforts, 60 per cent of cancer patients at the hospital are first diagnosed when they are already in the advanced stages of cancer. Early detection saves lives, leads to fewer complications and better outcomes.

According to HAAD projection report Abu Dhabi will need 4,800 new doctors and 13,000 new nurses by 2022. And the Director General of the DHA estimated that Dubai will need 7,323 more doctors and 8,510 nurses over the next decade.

In UAE, approximately 4500 new cases of cancer are reported every year, which equals to 12 new cancer cases a day, according to Abu Dhabi Health Authority.

The UAE is determined to bring down cancer fatalities by nearly 18% by 2021. Reducing the number of deaths due to cancer is one of the UAE National Agenda.